
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Loading…
Data from Twelve Data. Prices may be delayed.
No analyst coverage available.
Initial Jobless Claims
8:30 AM ET

Bitcoin (BTC)
71,271 −3.56%

Ethereum (ETH)
2,014 −1.94%

Solana (SOL)
82 −2.25%

Corporate PresentationNov 4, 2026
electroCore, Inc. is a medical device company developing non-invasive vagus nerve stimulation (nVNS) therapies. Their lead product, gammaCore, is a prescription-only nVNS therapy for the acute treatment of migraine and episodic cluster headaches in adults. The gammaCore Sapphire is a portable, rechargeable, and refillable device designed for long-term use. Founded in 2005, electroCore is headquartered in Rockaway, New Jersey.
Generated by AI